Internal Medicine, Pulmonary Disease · Dallas, TX
NPI
1184714768
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3410 Worth St., Suite 250
Dallas, TX, 75246
Phone (214) 820-6856
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
943 services
Medicare patients, 2024
117
Average age 70
Drug cost, 2024
$816K
3,375 prescriptions
Company payments, 2025
$3,419
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Todd Grazia was code 94010 (pulmonary function testing), 216 times for 78 patients. In total Todd Grazia billed 943 services in 22 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94010 Pulmonary Function Testing | Facility | 216 | 78 | $6.09 | $1,316 |
| 99215 Office E&M - Established | Facility | 195 | 75 | $106.64 | $21K |
| 99232 Hospital E&M - Subsequent | Facility | 126 | 36 | $60.06 | $7,567 |
| 99233 Hospital E&M - Subsequent | Facility | 98 | 36 | $90.63 | $8,881 |
| 99291 Critical Care E&M | Facility | 64 | 11 | $164.54 | $11K |
| 94729 Pulmonary Function Testing | Facility | 39 | 38 | $6.74 | $263 |
| 94618 Pulmonary Function Testing | Facility | 37 | 35 | $16.93 | $626 |
| 94726 Pulmonary Function Testing | Facility | 35 | 35 | $9.09 | $318 |
| 99231 Hospital E&M - Subsequent | Facility | 30 | 16 | $38.40 | $1,152 |
| 31624 Bronchoscopy | Facility | 26 | 18 | $12.50 | $325 |
| 99239 Hospital Discharge Management | Facility | 20 | 18 | $82.39 | $1,648 |
| 99222 Hospital E&M - Initial | Facility | 16 | 16 | $100.94 | $1,615 |
| 31628 Bronchoscopy | Facility | 12 | 11 | $134.11 | $1,609 |
By year: 2022 $39K for 599 services; 2023 $42K for 803 services; 2024 $59K for 943 services.
Medicare prescription drug claims, 2024
In 2024, the drug Todd Grazia prescribed most often to Medicare patients was Azithromycin, with 239 prescriptions and refills. In total Todd Grazia wrote 3,375 Medicare prescriptions that cost $816K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azithromycin Generic | 239 | 603 | 72 | $5,006 |
| Prednisone Generic | 227 | 499 | 58 | $2,024 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 180 | 473 | 63 | $1,792 |
| Pantoprazole Sodium Generic | 177 | 494 | 54 | $3,284 |
| Itraconazole Generic | 156 | 296 | 43 | $20K |
| Valacyclovir Valacyclovir Hcl | 152 | 386 | 51 | $16K |
| Metoprolol Tartrate Generic | 95 | 273 | 39 | $810 |
| Eliquis Apixaban | 91 | 183 | 28 | $106K |
| Tacrolimus Generic | 84 | 205 | 25 | $4,730 |
| Furosemide Generic | 75 | 202 | 25 | $487 |
| Valganciclovir Hcl Generic | 75 | 186 | 32 | $21K |
| Atorvastatin Calcium Generic | 66 | 195 | 24 | $1,011 |
| Rosuvastatin Calcium Generic | 65 | 171 | 18 | $958 |
| Pravastatin Sodium Generic | 58 | 164 | 19 | $948 |
| Gabapentin Generic | 53 | 113 | 19 | $1,294 |
Brand drugs: 352 claims; generic drugs: 2,988 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Todd Grazia $3,419 ($3,419 in general payments such as food, travel and fees) from 10 companies. The largest payer was Invivyd Inc with $2,700.
| Company | Payments | Amount |
|---|---|---|
| Invivyd Inc IVVD | 1 | $2,700 |
| La Jolla Pharmaceutical Company | 6 | $341 |
| Insmed, Inc. INSM | 3 | $81.54 |
| Merck Sharp & Dohme LLC MRK | 3 | $74.17 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $65.48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55.97 |
| Grifols USA, LLC | 2 | $45.99 |
| GlaxoSmithKline, LLC. GSK | 2 | $34.66 |
| Verona Pharma, Inc. VRNA | 1 | $20.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.